About Mary
Mary’s experience encompasses patent prosecution, litigation, reissue and reexamination, post-grant proceedings, licensing, due diligence, and opinions. She provides intellectual property counsel to a variety of clients, including multinational corporations, mid-cap companies, and start-up biotech and medical-device companies. Mary also provides counsel related to issues involving regulatory matters before the U.S. Food and Drug Administration. She works with emerging-growth companies, both domestically and internationally, and has been involved with financial transactions involving initial public offerings, sales and procurement of assets, and mergers and acquisitions.